HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

Manufacturer: Sincerus Florida, LLC
Effective date: 2019-05-06
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 20:28:35

Label at a glance#

ProductHYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

Active ingredientHYALURONATE SODIUM, TAZAROTENE

Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

SIncerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

Active, inactive

COMPONENTS

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%. Cream 30 gm

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sdf

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TAZAROTENE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a107c35c-2cb4-4734-a92b-e9ed5cfc34d6	Product name	2	20260220
5993ea1b-833d-fa4b-caad-a0d477537538	Product name	5	20250305
c24b0f4e-b27e-8e2b-a129-1b5a6d72c459	Product name	2	20231128
18da2240-e326-4d63-90cd-d6bb15f662a0	Product name	1	20200604
a32b252c-8cd2-cc4a-c64c-4b9d3916df9e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
72934-2094-2	2021-01-29	C162847	48780-1	ba0f9c33-26d1-a910-e053-dadaa90a0b85	HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72934-2094-2	HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%	30 g in 1 BOTTLE, PUMP	CREAM	30		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72934-2094	HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% CREAM [SINCERUS FLORIDA, LLC]	1	Legacy NDC, 1 package rows	20190507_8838d911-0db2-f66e-e053-2995a90acb53.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
HYALURONATE SODIUM
HYALURONIC ACID
TAZAROTENE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
72934-2094	72934-2094-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
HYALURONATE SODIUM	YSE9PPT4TH	ACTIB
TAZAROTENE	81BDR9Y8PS	ACTIB

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
8838d911-0db3-f66e-e053-2995a90acb53			8838d911-0db2-f66e-e053-2995a90acb53	2019-05-06	Adverse reactions	Exact identifier spl id: 8838d911-0db3-f66e-e053-2995a90acb53 spl set id: 8838d911-0db2-f66e-e053-2995a90acb53

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.